Journal
NEUROBIOLOGY OF AGING
Volume 30, Issue 10, Pages 1523-1534Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2009.06.001
Keywords
Cystathionine-beta-synthase; Microglia; Alzheimer disease; Parkinson disease; Aging; Neuroinflammation; NaSH
Categories
Funding
- Pacific Alzheimer Research Foundation
Ask authors/readers for more resources
Hydrogen sulfide (H2S) is an essential physiological product in brain. We investigated the expression of cystathionine-beta-synthase (CBS) and cystathionine-gamma-lyase (CGL), the two H2S synthesizing enzymes, in human cell lines and in human brain. Only astrocytes were strongly immunostained for CBS. Cultured astrocytes synthesized H2S at the rate of 15.06 mu mol/g protein/h, which was 7.57 fold higher than microglial cells, 10.27 fold higher than SH-SY5Y cells and 11.32 fold higher than NT-2 cells. The H2S synthesis in all these cell types was inhibited by the CBS inhibitor hydroxylamine, but not by the CGL inhibitor propargylglycine (PAG). Synthesis of H2S by HUVEC cells was inhibited by PAG but not by hydroxylamine indicating that these vascular cells utilize CGL but not CBS. Inflammatory activation of microglia and astrocytes caused induction of NF kappa B, release of the inflammatory mediators TNF alpha, IL-6 and nitrite ions, down-regulation of CBS, and down-regulation of H2S synthesis. There was no effect of such treatment on HUVEC cells. The effects were partially reversed by pretreatment of cells with the H2S releasing agent NaSH. These data indicate that H2S is an endogenous antiinflammatory and neuroprotective agent under the synthetic control of CBS. H2S releasing drugs may have therapeutic potential in neurodegenerative disorders of aging such as Alzheimer disease and Parkinson disease. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available